Twenty-Four–hour Duration of Effect of Intranasal Corticosteroids for Seasonal Allergic Rhinitis Symptoms: Clinical Evidence and Relevance

Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study

(2013) Craig LaForce et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Mometasone furoate nasal spray for moderate-to-severe nasal congestion in subjects with seasonal allergic rhinitis

(2011) Eli O. Meltzer et al.   ALLERGY AND ASTHMA PROCEEDINGS

Allergic rhinitis: Direct and indirect costs

(2010) Michael S. Blaiss   ALLERGY AND ASTHMA PROCEEDINGS

Mometasone Furoate Nasal Spray Provides Early, Continuing Relief of Nasal Congestion and Improves Nasal Patency in Allergic Patients

(2010) Anne Marie Salapatek et al.   American Journal of Rhinology & Allergy

Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis

(2010) Robert A Nathan et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis

(2010) Robert Anolik   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class

(2010) Michael Benninger et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep

(2010) Eli O. Meltzer et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device

(2010) Frank C. Hampel et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review

(2010) G. J. Rodrigo et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis

(2010) Bruce M. Prenner et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision

(2010) Jan L. Brożek et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America survey

(2009) Robert A. Nathan et al.   ALLERGY AND ASTHMA PROCEEDINGS

Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy

(2009) Charles P. Andrews et al.   ALLERGY AND ASTHMA PROCEEDINGS

Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 μg in the treatment of seasonal allergic rhinitis

(2009) Michael A. Kaliner et al.   ALLERGY AND ASTHMA PROCEEDINGS

Effectiveness of fluticasone furoate 110 μg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen

(2009) Robert Jacobs et al.   CURRENT MEDICAL RESEARCH AND OPINION

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

(2008) J. Bousquet et al.   ALLERGY

Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber

(2008) Petra Zieglmayer et al.   CURRENT MEDICAL RESEARCH AND OPINION

Duration of Action of Mometasone Furoate Nasal Spray in Subjects with Symptoms of Seasonal Allergic Rhinitis Induced in an Environmental Exposure Chamber

(2008) S VARGHESE et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY